2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[5,10-dihydroxy-8,8-dimethyl-6-(2-methylpropanoyl)-2-oxo-4-phenyl-2H,8H,9H,10H-pyrano[2,3-h]chromen-9-yl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid

Metabolite details

Identifier

RAKBXUNZHUPFFC-UHFFFAOYSA-N

InChI Key

RAKBXUNZHUPFFC-UHFFFAOYSA-N

IUPAC name

2-amino-5-[[1-(carboxymethylamino)-3-[[5,10-dihydroxy-8,8-dimethyl-6-(2-methylpropanoyl)-2-oxo-4-phenyl-9,10-dihydropyrano[2,3-h]chromen-9-yl]sulanyl]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

Preferred name

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[5,10-dihydroxy-8,8-dimethyl-6-(2-methylpropanoyl)-2-oxo-4-phenyl-2H,8H,9H,10H-pyrano[2,3-h]chromen-9-yl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid

INN name

—

Synonym

—

ChEBI

CHEBI:180802

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum

Observed in differential profiles

• Control_vs_CSD